The Traderszone Network

Published in TZ Latest News 3 November, 2017 by The TZ Newswire Staff

Presentations at ASN Kidney Week 2017 Highlight ChemoCentryx Platform in Treatment of Kidney Diseases ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS)

— Rapid reduction in kidney inflammation following avacopan treatment in patients with ANCA-Associated Vasculitis revealed by analysis of markers of kidney damage —

— Podocyte protection demonstrated with CCR2 inhibitor CCX140, supporting differentiated potential treatment option for patients with Focal Segmental Glomerulosclerosis —